NO179694C - Farmasöytiske preparater inneholdende ranitidinderivater - Google Patents

Farmasöytiske preparater inneholdende ranitidinderivater

Info

Publication number
NO179694C
NO179694C NO920408A NO920408A NO179694C NO 179694 C NO179694 C NO 179694C NO 920408 A NO920408 A NO 920408A NO 920408 A NO920408 A NO 920408A NO 179694 C NO179694 C NO 179694C
Authority
NO
Norway
Prior art keywords
derivatives
pharmaceutical preparations
preparations containing
containing ranitidine
ranitidine
Prior art date
Application number
NO920408A
Other languages
English (en)
Norwegian (no)
Other versions
NO920408L (no
NO179694B (no
NO920408D0 (no
Inventor
Norman Richard Smith
Colin Roy Heppenstall
Stephen John Douglas
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB909019875A priority Critical patent/GB9019875D0/en
Priority to IL9942891A priority patent/IL99428A/en
Priority to CA002050970A priority patent/CA2050970C/en
Priority to BE9100841A priority patent/BE1005115A5/fr
Priority to AT0180191A priority patent/AT405134B/de
Priority to KR1019910015760A priority patent/KR100196308B1/ko
Priority to DE4130061A priority patent/DE4130061A1/de
Priority to DK159191A priority patent/DK159191A/da
Priority to ITRM910673A priority patent/IT1249696B/it
Priority to ZA917176A priority patent/ZA917176B/xx
Priority to NL9101533A priority patent/NL194907C/nl
Priority to CH2655/91A priority patent/CH683068A5/fr
Priority to AU83757/91A priority patent/AU640816B2/en
Priority to FR9111146A priority patent/FR2666508B1/fr
Priority to IE319191A priority patent/IE65049B1/en
Priority to GB9119284A priority patent/GB2248185B/en
Priority to NZ239731A priority patent/NZ239731A/en
Priority to JP3230571A priority patent/JPH0692849A/ja
Priority to SE9102604A priority patent/SE509694C2/sv
Priority to NO920408A priority patent/NO179694C/no
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO920408D0 publication Critical patent/NO920408D0/no
Priority to AT92103741T priority patent/ATE122883T1/de
Priority to AU13347/92A priority patent/AU1334792A/en
Priority to MX9101009A priority patent/MX9101009A/es
Priority to SK1060-94A priority patent/SK279591B6/sk
Priority to EP92103741A priority patent/EP0558779B1/de
Priority to PCT/EP1992/000498 priority patent/WO1993017679A1/en
Priority to ES92103741T priority patent/ES2072647T3/es
Priority to RO94-01459A priority patent/RO112084B1/ro
Priority to RU94040869A priority patent/RU2108097C1/ru
Priority to DE69202696T priority patent/DE69202696D1/de
Publication of NO920408L publication Critical patent/NO920408L/no
Priority to US08/215,658 priority patent/US5456925A/en
Priority to HK60894A priority patent/HK60894A/xx
Priority to OA60553A priority patent/OA10093A/en
Priority to BG99021A priority patent/BG61931B1/bg
Priority to FI944047A priority patent/FI944047A/fi
Priority to HU95P/P00511P priority patent/HU211846A9/hu
Publication of NO179694B publication Critical patent/NO179694B/no
Publication of NO179694C publication Critical patent/NO179694C/no
Priority to CY198897A priority patent/CY1988A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Furan Compounds (AREA)
NO920408A 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater NO179694C (no)

Priority Applications (37)

Application Number Priority Date Filing Date Title
GB909019875A GB9019875D0 (en) 1990-09-11 1990-09-11 Pharmaceutical compositions
IL9942891A IL99428A (en) 1990-09-11 1991-09-06 Pharmaceutical preparations containing ranitidine bismuth carborsilate
CA002050970A CA2050970C (en) 1990-09-11 1991-09-09 Pharmaceutical compositions containing furan derivatives
AT0180191A AT405134B (de) 1990-09-11 1991-09-10 Furanderivate enthaltende pharmazeutische präparate
KR1019910015760A KR100196308B1 (ko) 1990-09-11 1991-09-10 푸란 유도체를 함유하는 제약 조성물
DE4130061A DE4130061A1 (de) 1990-09-11 1991-09-10 Furanderivate enthaltende pharmazeutische praeparate
DK159191A DK159191A (da) 1990-09-11 1991-09-10 Farmaceutiske praeparater
BE9100841A BE1005115A5 (fr) 1990-09-11 1991-09-10 Compositions pharmaceutiques contenant des derives de furanne.
ZA917176A ZA917176B (en) 1990-09-11 1991-09-10 Pharmaceutical compositions containing furan derivatives
NL9101533A NL194907C (nl) 1990-09-11 1991-09-10 Farmaceutische samenstellingen die furaanderivaten bevatten.
CH2655/91A CH683068A5 (fr) 1990-09-11 1991-09-10 Compositions pharmaceutiques contenant des dérivés de furanne.
AU83757/91A AU640816B2 (en) 1990-09-11 1991-09-10 Pharmaceutical compositions containing furan derivatives
FR9111146A FR2666508B1 (fr) 1990-09-11 1991-09-10 Compositions pharmaceutiques contenant des derives de furanne.
IE319191A IE65049B1 (en) 1990-09-11 1991-09-10 Pharmaceutical compositions containing furan derivatives
GB9119284A GB2248185B (en) 1990-09-11 1991-09-10 Pharmaceutical compositions containing furan derivatives
NZ239731A NZ239731A (en) 1990-09-11 1991-09-10 Oral medicaments containing ranitidine bismuth tartrate or citrate and an alkaline salt
JP3230571A JPH0692849A (ja) 1990-09-11 1991-09-10 フラン誘導体を含有する医薬組成物
SE9102604A SE509694C2 (sv) 1990-09-11 1991-09-10 Farmaceutiska kompositioner innehållande ranitidin/vismut karboxylsyra salter
ITRM910673A IT1249696B (it) 1990-09-11 1991-09-10 Composizioni farmaceutiche contenenti derivati di furano e procedimento per prepararle.
NO920408A NO179694C (no) 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater
AU13347/92A AU1334792A (en) 1990-09-11 1992-03-05 Compositions containing ranitidine/bismuth carboxylates salts
RU94040869A RU2108097C1 (ru) 1990-09-11 1992-03-05 Фармацевтическая композиция, содержащая соль ранитидина и карбоксилата висмута, и способ ее получения
DE69202696T DE69202696D1 (de) 1990-09-11 1992-03-05 Arzneimittel enthaltend Ranitidin/Wismutcarboxylat-Salze.
MX9101009A MX9101009A (es) 1990-09-11 1992-03-05 Composicion farmaceutica que contiene derivados de furano y procedimiento para su preparacion
SK1060-94A SK279591B6 (sk) 1990-09-11 1992-03-05 Farmaceutický prostriedok
EP92103741A EP0558779B1 (de) 1990-09-11 1992-03-05 Arzneimittel enthaltend Ranitidin/Wismutcarboxylat-Salze
PCT/EP1992/000498 WO1993017679A1 (en) 1990-09-11 1992-03-05 Compositions containing ranitidine/bismuth carboxylates salts
ES92103741T ES2072647T3 (es) 1990-09-11 1992-03-05 Composiciones que contienen sales de ranitidina/carboxilato de bismuto.
RO94-01459A RO112084B1 (ro) 1990-09-11 1992-03-05 Compozitie farmaceutica care contine derivati de furan si procedeu de obtinere
AT92103741T ATE122883T1 (de) 1990-09-11 1992-03-05 Arzneimittel enthaltend ranitidin/wismutcarboxylat-salze.
US08/215,658 US5456925A (en) 1990-09-11 1994-03-22 Pharmaceutical compositions containing furan derivatives
HK60894A HK60894A (en) 1990-09-11 1994-06-23 Pharmaceutical compositions containing furan derivatives
OA60553A OA10093A (en) 1990-09-11 1994-08-12 Pharmaceutical compositions containing furan derivatives
BG99021A BG61931B1 (bg) 1990-09-11 1994-09-01 Фармацевтични състави, съдържащи производни на фурана
FI944047A FI944047A (fi) 1990-09-11 1994-09-02 Koostumuksia, jotka sisältävät ranitidiini/vismuttikarboksylaattisuoloja
HU95P/P00511P HU211846A9 (en) 1990-09-11 1995-06-28 Pharmaceutical compositions containing furan derivatives
CY198897A CY1988A (en) 1990-09-11 1997-09-05 Pharmaceutical compositions containing furan derivatives

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909019875A GB9019875D0 (en) 1990-09-11 1990-09-11 Pharmaceutical compositions
NO920408A NO179694C (no) 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater
PCT/EP1992/000498 WO1993017679A1 (en) 1990-09-11 1992-03-05 Compositions containing ranitidine/bismuth carboxylates salts

Publications (4)

Publication Number Publication Date
NO920408D0 NO920408D0 (no) 1992-01-30
NO920408L NO920408L (no) 1993-08-02
NO179694B NO179694B (no) 1996-08-26
NO179694C true NO179694C (no) 1996-12-04

Family

ID=47884627

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920408A NO179694C (no) 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater

Country Status (33)

Country Link
US (1) US5456925A (de)
EP (1) EP0558779B1 (de)
JP (1) JPH0692849A (de)
KR (1) KR100196308B1 (de)
AT (2) AT405134B (de)
AU (2) AU640816B2 (de)
BE (1) BE1005115A5 (de)
BG (1) BG61931B1 (de)
CA (1) CA2050970C (de)
CH (1) CH683068A5 (de)
CY (1) CY1988A (de)
DE (2) DE4130061A1 (de)
DK (1) DK159191A (de)
ES (1) ES2072647T3 (de)
FI (1) FI944047A (de)
FR (1) FR2666508B1 (de)
GB (2) GB9019875D0 (de)
HK (1) HK60894A (de)
HU (1) HU211846A9 (de)
IE (1) IE65049B1 (de)
IL (1) IL99428A (de)
IT (1) IT1249696B (de)
MX (1) MX9101009A (de)
NL (1) NL194907C (de)
NO (1) NO179694C (de)
NZ (1) NZ239731A (de)
OA (1) OA10093A (de)
RO (1) RO112084B1 (de)
RU (1) RU2108097C1 (de)
SE (1) SE509694C2 (de)
SK (1) SK279591B6 (de)
WO (1) WO1993017679A1 (de)
ZA (1) ZA917176B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
DE69620582T2 (de) * 1995-01-26 2002-11-07 Nycomed Imaging As, Oslo Verwendung von WISMUTVERBINDUNGEN zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
WO2000010562A1 (fr) * 1998-08-18 2000-03-02 Leonidov Nikolai B Forme physiquement stable et amorphe aux rayons x de ranitidine d'hydrochlorure ayant une action anti-ulcere accrue, et procede de production
EP1104673A1 (de) * 1999-11-30 2001-06-06 Bayer Classics Ein Hydrogencarbonat enthaltendes sprengmittelfreies Arzneimittel
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
MX337488B (es) * 2008-07-21 2016-03-08 Si Group Inc Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en preparar formas de dosificacion solidas no efervescentes.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608257A (en) * 1984-01-03 1986-08-26 Board Of Regents For Oklahoma State University Composition and method for treating heat stress
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
EP0282132B1 (de) * 1987-03-09 1992-09-30 The Procter & Gamble Company Zusammensetzungen und ihre Verwendung zur Behandlung von Magen-Darmstörungen
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
CH679582A5 (de) * 1988-07-18 1992-03-13 Glaxo Group Ltd
DE3865201D1 (de) * 1988-10-08 1991-10-31 Pfleger R Chem Fab Fluessiges, wismuthaltiges arzneipraeparat, verfahren zum herstellen desselben und seine verwendung.
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
JPH0692849A (ja) 1994-04-05
DE69202696D1 (de) 1995-06-29
AU640816B2 (en) 1993-09-02
WO1993017679A1 (en) 1993-09-16
NO920408L (no) 1993-08-02
CY1988A (en) 1997-09-05
BE1005115A5 (fr) 1993-04-27
DK159191A (da) 1992-03-12
MX9101009A (es) 1992-05-04
HK60894A (en) 1994-07-08
CA2050970A1 (en) 1992-03-12
GB9019875D0 (en) 1990-10-24
NL194907C (nl) 2003-07-04
GB9119284D0 (en) 1991-10-23
ITRM910673A0 (it) 1991-09-10
NO179694B (no) 1996-08-26
EP0558779A1 (de) 1993-09-08
KR100196308B1 (ko) 1999-06-15
IE65049B1 (en) 1995-10-04
SK279591B6 (sk) 1999-01-11
DE4130061A1 (de) 1992-03-12
AT405134B (de) 1999-05-25
RU2108097C1 (ru) 1998-04-10
FI944047A0 (fi) 1994-09-02
ATE122883T1 (de) 1995-06-15
OA10093A (en) 1996-12-18
NL194907B (nl) 2003-03-03
SE9102604L (sv) 1992-03-12
ZA917176B (en) 1992-06-24
GB2248185B (en) 1994-02-02
CH683068A5 (fr) 1994-01-14
SK106094A3 (en) 1995-02-08
HU211846A9 (en) 1995-12-28
AU8375791A (en) 1992-03-19
NL9101533A (nl) 1992-04-01
NO920408D0 (no) 1992-01-30
ES2072647T3 (es) 1995-07-16
FI944047A (fi) 1994-09-02
IT1249696B (it) 1995-03-09
RO112084B1 (ro) 1997-05-30
GB2248185A (en) 1992-04-01
US5456925A (en) 1995-10-10
EP0558779B1 (de) 1995-05-24
KR920005984A (ko) 1992-04-27
CA2050970C (en) 2002-11-19
BG61931B1 (bg) 1998-10-30
AU1334792A (en) 1993-10-05
ATA180191A (de) 1998-10-15
IE913191A1 (en) 1992-04-22
NZ239731A (en) 1993-10-26
SE509694C2 (sv) 1999-02-22
IL99428A0 (en) 1992-08-18
FR2666508A1 (fr) 1992-03-13
DK159191D0 (da) 1991-09-10
BG99021A (bg) 1995-06-30
IL99428A (en) 1996-06-18
SE9102604D0 (sv) 1991-09-10
ITRM910673A1 (it) 1993-03-10
FR2666508B1 (fr) 1994-02-18

Similar Documents

Publication Publication Date Title
DE59010810D1 (de) Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
DK0609210T3 (da) Optisk aktivt 5H-pyrrolo(3,4-b)pyrazinderivat, dets fremstilling og farmaceutiske præparater deraf
NO920408L (no) Farmasoeytiske preparater inneholdende furanderivater
DK585886A (da) Immunstimulerende middel og anvendelse deraf
ES2058651T3 (es) Uso derivados de guanidina para la fabricacion de un medicamento con actividad antagonista de npy.
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
NO893142L (no) Fremgangsmaate for preservering av oftalmologiske opploesninger og sammensetninger for formaalet.
DK403789A (da) Et nyt antibiotikum, mersacidin, dets fremstilling og anvendelse som laegemiddel
DE59101404D1 (de) Topische Präparate.
DK578589A (da) Farmaceutisk praeparat indeholdende labdanterpenoidderivater og pyrimido(6,1-a)isoquinolin-4-onderivater, dets fremstilling og anvendelse
DK179786D0 (da) (-)-1beta-ethyl-1alfa-hydroxylmethyl-1,2,3,4,6,7,12,12balfa-octa-hydroindolo(2,3-a)quinolizin og syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
DE3869156D1 (de) Fungizide 2-anilinthiazoline.
DE3865642D1 (de) Pharmazeutische zubereitung zur cholelitholyse.
NO873385D0 (no) Oksiran-pseudooligosakkarider, fremgangsmaate til deres fremstilling, deres anvendelse og farmasoeytiske preparater.
GB2162746A (en) Antiacidotic medicinal agent
IT8723046A0 (it) Agente nootropo, sua preparazione e impiego.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JULY 2002